These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 18794608

  • 1. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
    Cereto F, Herranz X, Moreno E, Andreu A, Vergara M, Fontanals D, Roget M, Simó M, González A, Prats G, Genescà J.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
    [Abstract] [Full Text] [Related]

  • 2. Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.
    Bert F, Panhard X, Johnson J, Lecuyer H, Moreau R, Le Grand J, Johnston B, Sinègre M, Valla D, Nicolas-Chanoine MH.
    Clin Microbiol Infect; 2008 Nov; 14(11):1034-40. PubMed ID: 19040475
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR, Tatu-Chiţoiu D, Nica M, Ciontea SA, Palade AM, Condei M, Damian M.
    Roum Arch Microbiol Immunol; 2008 Nov; 67(1-2):23-9. PubMed ID: 19284163
    [Abstract] [Full Text] [Related]

  • 4. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J, Vila MC, Soriano G, Miñana J, Gana J, Mirelis B, Novella MT, Coll S, Sábat M, Andreu M, Prats G, Solá R, Guarner C.
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [Abstract] [Full Text] [Related]

  • 5. Phylogenetic background and virulence genotype of ciprofloxacin-susceptible and ciprofloxacin-resistant Escherichia coli strains of human and avian origin.
    Graziani C, Luzzi I, Corro M, Tomei F, Parisi G, Giufre M, Morabito S, Caprioli A, Cerquetti M.
    J Infect Dis; 2009 Apr 15; 199(8):1209-17. PubMed ID: 19226230
    [Abstract] [Full Text] [Related]

  • 6. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR, Such J, Gutiérrez A, Pérez-Mateo M, Plaza J, Arroyo A.
    Med Clin (Barc); 1999 Sep 11; 113(7):241-5. PubMed ID: 10544377
    [Abstract] [Full Text] [Related]

  • 7. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
    Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A.
    J Antimicrob Chemother; 2006 Feb 11; 57(2):204-11. PubMed ID: 16390858
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals.
    Ho PL, Wong RC, Chow KH, Que TL.
    Lett Appl Microbiol; 2009 Nov 11; 49(5):627-34. PubMed ID: 19780962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
    Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G.
    J Antimicrob Chemother; 2008 Mar 11; 61(3):721-8. PubMed ID: 18218645
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE, van Nieuwkoop C, Paltansing S, van't Wout JW, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, Blom JW, van Dissel JT.
    J Antimicrob Chemother; 2011 Mar 11; 66(3):650-6. PubMed ID: 21123286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.